TGF-β signaling in cancer -: a double-edged sword

被引：572

作者：

Akhurst, RJ ^{[1
]}

Derynck, R

机构：

[1] Univ Calif San Francisco, Mt Zion Canc Res Inst, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Growth & Dev, Cell Biol Program, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Dept Growth & Dev, Program Dev Biol, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA

[5] Univ Calif San Francisco, Dept Growth & Dev, Program Dev Biol, San Francisco, CA 94143 USA

来源：

TRENDS IN CELL BIOLOGY | 2001年 / 11卷 / 11期

关键词：

D O I：

10.1016/S0962-8924(01)02130-4

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Transforming growth factor (TGF) beta1 is a potent growth inhibitor, with tumor-suppressing activity. Cancers are often refractile to this growth inhibition either because of genetic loss of TGF-beta signaling components or, more commonly, because of downstream perturbation of the signaling pathway, such as by Ras activation. Carcinomas often secrete excess TGF-beta1 and respond to it by enhanced invasion and metastasis. Therapeutic approaches should aim to inhibit the TGF-beta -induced invasive phenotype, but also to retain its growth-inhibitory and apoptosis-inducing effects.

引用

页码：S44 / S51

页数：8

共 78 条

[1] Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma
Adler, HL
McCurdy, MA
Kattan, MW
Timme, TL
Scardino, PT
Thompson, TC
[J]. JOURNAL OF UROLOGY, 1999, 161 (01) : 182 - 187
[2] LOCALIZED PRODUCTION OF TGF-BETA MESSENGER-RNA IN TUMOR PROMOTER-STIMULATED MOUSE EPIDERMIS
AKHURST, RJ
FEE, F
BALMAIN, A
[J]. NATURE, 1988, 331 (6154) : 363 - 365
[3] Ananth S, 1999, CANCER RES, V59, P2210
[4] Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-β
Arteaga, CL
Koli, KM
Dugger, TC
Clarke, R
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (01): : 46 - 53
[5] ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION
ARTEAGA, CL
HURD, SD
WINNIER, AR
JOHNSON, MD
FENDLY, BM
FORBES, JT
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2569 - 2576
[6] Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
Arthur, HM
Ure, J
Smith, AJH
Renforth, G
Wilson, DI
Torsney, E
Charlton, R
Parums, DV
Jowett, T
Marchuk, DA
Burn, J
Diamond, AG
[J]. DEVELOPMENTAL BIOLOGY, 2000, 217 (01) : 42 - 53
[7] Bandyopadhyay A, 1999, CANCER RES, V59, P5041
[8] BATTIFORA H, 1976, CANCER, V37, P2275, DOI 10.1002/1097-0142(197605)37:5<2275::AID-CNCR2820370518>3.0.CO
[9] 2-3
[10] The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2
Berg, JN
Gallione, CJ
Stenzel, TT
Johnson, DW
Allen, WP
Schwartz, CE
Jackson, CE
Porteous, MEM
Marchuk, DA
[J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) : 60 - 67

← 1 2 3 4 5 6 7 8 →